# Hyperglycemia and insulin resistance during glucagon infusion.

> PubMed lists PMID 5020833 in Connecticut medicine as Journal Article, with publication-date metadata of 1972-04 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-5020833-glucagon:v1`
- Evidence domain: Literature metadata
- Date in source: 2004-11-17
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-5020833-glucagon/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-5020833-glucagon-v1.json
- Content SHA-256: `759cdf78e965166089170099fdecd28a6bf523fb6369f8958baf9602c8e90d8c`

## Claims and source pins

### Headline

Hyperglycemia and insulin resistance during glucagon infusion. ([`pubmed-observation-pmid-5020833-2004-11-17-dcfd08f74148`](#source-pubmed-observation-pmid-5020833-2004-11-17-dcfd08f74148))

### Summary

PubMed lists PMID 5020833 in Connecticut medicine as Journal Article, with publication-date metadata of 1972-04 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-5020833-2004-11-17-dcfd08f74148`](#source-pubmed-observation-pmid-5020833-2004-11-17-dcfd08f74148))

### Paragraph 1

PubMed lists PMID 5020833 in Connecticut medicine as Journal Article, with publication-date metadata of 1972-04 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-5020833-2004-11-17-dcfd08f74148`](#source-pubmed-observation-pmid-5020833-2004-11-17-dcfd08f74148))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-5020833-2004-11-17-dcfd08f74148`](#source-pubmed-observation-pmid-5020833-2004-11-17-dcfd08f74148))

## Sources

<a id="source-pubmed-observation-pmid-5020833-2004-11-17-dcfd08f74148"></a>
- **Hyperglycemia and insulin resistance during glucagon infusion. · retained source version 1:2004-11-17:current:dcfd08f74148506aa3f133f460a9777b8640d0b081c5ab8f08ecb1f93357b56c** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/5020833/) (`pubmed-observation-pmid-5020833-2004-11-17-dcfd08f74148`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Hyperglycemia and insulin resistance during glucagon infusion." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-5020833-glucagon-v1.json SHA-256: 759cdf78e965166089170099fdecd28a6bf523fb6369f8958baf9602c8e90d8c.